LAM LAB. EDIZIONE CENTRO - LABORATORIO DI IDEE E PRATICA CLINICA

1. 1.Raffaele Palmieri et al.. Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351. Palmieri R, Guolo F, Fianchi L, Ferrara F, Minetto P, Martelli MP, Riva C, Chiusolo P, Rondoni M, Capria S, Minotti C, Pilo F, Perrone S, Corbingi A, Grimaldi F, De Luca G, Fili C, Alati C, Mannelli F, Lessi F, Marchesi F, Brunetti L, Capelli D, Piccioni AL, Vetro C, Palumbo FE, Mazzone C, Sperotto A, Luzi G, Dargenio M, Mariani S, Cerrano M, Mulè A, Di Veroli A, Meddi E, Moretti F, Papayannidis C, Isidori A, Ferrari A, Galimberti S, Cilloni D, Breccia M, Lanza F, Gottardi M, Cairoli R, Candoni A, Pagano L, Todisco E, Lemoli RM, Venditti A, Buccisano F. Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351. Blood Adv. 2026 Feb 24;10(4):1126-1133. doi: 10.1182/bloodadvances.2025017089. PMID: 41346286; PMCID: PMC12915183.. 2026
   Articolo scientificoPalmieri R, Guolo F, Fianchi L, Ferrara F, Minetto P, Martelli MP, Riva C, Chiusolo P, Rondoni M, Capria S, Minotti C, Pilo F, Perrone S, Corbingi A, Grimaldi F, De Luca G, Fili C, Alati C, Mannelli F, Lessi F, Marchesi F, Brunetti L, Capelli D, Piccioni AL, Vetro C, Palumbo FE, Mazzone C, Sperotto A, Luzi G, Dargenio M, Mariani S, Cerrano M, Mulè A, Di Veroli A, Meddi E, Moretti F, Papayannidis C, Isidori A, Ferrari A, Galimberti S, Cilloni D, Breccia M, Lanza F, Gottardi M, Cairoli R, Candoni A, Pagano L, Todisco E, Lemoli RM, Venditti A, Buccisano F. Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351. Blood Adv. 2026 Feb 24;10(4):1126-1133. doi: 10.1182/bloodadvances.2025017089. PMID: 41346286; PMCID: PMC12915183.Leggi il PDF gratuito
2. 2.Calogero Vetro et al.. NPM1 and IDH1/2 Mutations Show Limited Prognostic Impact in Relapsed/Refractory AML: Evidence From the AVALON Cohort. Vetro C, Azzali I, Petracci E, Papayannidis C, Eleuteri E, Palumbo FE, Federico V, Fracchiolla N, Zappasodi P, Martelli MP, Giannini MB, Brunetti L, Palmieri R, Nanni J, Simonetti G, Guolo F, Minetto P, Maurillo L, Gigli F, Billio A, Todisco E, Martinelli G, Marconi G. NPM1 and IDH1/2 Mutations Show Limited Prognostic Impact in Relapsed/Refractory AML: Evidence From the AVALON Cohort. Hematol Oncol. 2026 Jan;44(1):e70169. doi: 10.1002/hon.70169. PMID: 41527965; PMCID: PMC12797279.. 2026
   Articolo scientificoVetro C, Azzali I, Petracci E, Papayannidis C, Eleuteri E, Palumbo FE, Federico V, Fracchiolla N, Zappasodi P, Martelli MP, Giannini MB, Brunetti L, Palmieri R, Nanni J, Simonetti G, Guolo F, Minetto P, Maurillo L, Gigli F, Billio A, Todisco E, Martinelli G, Marconi G. NPM1 and IDH1/2 Mutations Show Limited Prognostic Impact in Relapsed/Refractory AML: Evidence From the AVALON Cohort. Hematol Oncol. 2026 Jan;44(1):e70169. doi: 10.1002/hon.70169. PMID: 41527965; PMCID: PMC12797279.Leggi il PDF gratuito
3. 3.Adriano Venditti et al.. Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Venditti A, Palmieri R, Maurillo L, Röllig C, Wierzbowska A, de Leeuw D, Efficace F, Curti A, Ngai LL, Tettero J, Adès L, Almeida A, Bullinger L, Dennis M, Esteve J, Ferrara F, Heuser M, Huls G, Lübbert M, Mehta P, Montesinos P, Pabst T, Récher C, Rossi G, Russell N, Sierra J, Stauder R, Vey N, Walter RB, Wang E, Nier S, Martins CG, Ossenkoppele G. Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood Adv. 2025 May 13;9(9):2207-2220. doi: 10.1182/bloodadvances.2024013744. PMID: 39913928; PMCID: PMC12083920.. 2025
   Articolo scientificoVenditti A, Palmieri R, Maurillo L, Röllig C, Wierzbowska A, de Leeuw D, Efficace F, Curti A, Ngai LL, Tettero J, Adès L, Almeida A, Bullinger L, Dennis M, Esteve J, Ferrara F, Heuser M, Huls G, Lübbert M, Mehta P, Montesinos P, Pabst T, Récher C, Rossi G, Russell N, Sierra J, Stauder R, Vey N, Walter RB, Wang E, Nier S, Martins CG, Ossenkoppele G. Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood Adv. 2025 May 13;9(9):2207-2220. doi: 10.1182/bloodadvances.2024013744. PMID: 39913928; PMCID: PMC12083920.Cerca su Google Scholar

I link ai libri possono contenere un codice affiliato Amazon: in qualità di affiliato, ECM Finder potrebbe ricevere una commissione sugli acquisti idonei, senza alcun costo aggiuntivo per te. I link ai paper rimandano alla fonte scientifica (DOI, versione open-access o ricerca accademica).